Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,240.50
-28.50 (-2.25%)
Oct 23, 2026, 12:47 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 152.26 billion as of October 22, 2026. It is the 7,452nd most valuable company in the world and the 426th biggest in India. Its market cap has increased by 34.26% in one year.
Market Cap
152.26B
Enterprise Value
145.00B
Revenue
25.90B
Global Rank
Country Rank
#426 India
PE Ratio
25.30
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 152.26B, an increase of 66.02%. That is a compound annual growth rate of 10.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 152.26B | 35.40% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 335.09B |
| Wockhardt | 309.76B |
| Piramal Pharma | 258.46B |
| Cohance Lifesciences | 175.11B |
| Eris Lifesciences | 155.44B |
| Alembic Pharmaceuticals | 155.35B |
| NATCO Pharma | 143.44B |
| Sudeep Pharma | 113.32B |